146 related articles for article (PubMed ID: 15100315)
21. Attenuation of experimental autoimmune demyelination in complement-deficient mice.
Nataf S; Carroll SL; Wetsel RA; Szalai AJ; Barnum SR
J Immunol; 2000 Nov; 165(10):5867-73. PubMed ID: 11067947
[TBL] [Abstract][Full Text] [Related]
22. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
[TBL] [Abstract][Full Text] [Related]
23. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
[TBL] [Abstract][Full Text] [Related]
24. Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.
Valentin-Torres A; Savarin C; Barnett J; Bergmann CC
J Neuroinflammation; 2018 Apr; 15(1):121. PubMed ID: 29690885
[TBL] [Abstract][Full Text] [Related]
25. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Yin LL; Lin LL; Zhang L; Li L
Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
[TBL] [Abstract][Full Text] [Related]
26. Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease.
Sabelko-Downes KA; Russell JH; Cross AH
J Neuroimmunol; 1999 Dec; 100(1-2):42-52. PubMed ID: 10695714
[TBL] [Abstract][Full Text] [Related]
27. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.
Hisahara S; Araki T; Sugiyama F; Yagami Ki; Suzuki M; Abe K; Yamamura K; Miyazaki J; Momoi T; Saruta T; Bernard CC; Okano H; Miura M
EMBO J; 2000 Feb; 19(3):341-8. PubMed ID: 10654933
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis.
Hövelmeyer N; Hao Z; Kranidioti K; Kassiotis G; Buch T; Frommer F; von Hoch L; Kramer D; Minichiello L; Kollias G; Lassmann H; Waisman A
J Immunol; 2005 Nov; 175(9):5875-84. PubMed ID: 16237080
[TBL] [Abstract][Full Text] [Related]
29. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
[TBL] [Abstract][Full Text] [Related]
30. Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes.
Chen L; Brosnan CF
J Immunol; 2006 Mar; 176(5):3115-26. PubMed ID: 16493071
[TBL] [Abstract][Full Text] [Related]
31. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
32. Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis.
Djerbi M; Abdul-Majid KB; Abedi-Valugerdi M; Olsson T; Harris RA; Grandien A
J Immunol; 2003 Feb; 170(4):2064-73. PubMed ID: 12574377
[TBL] [Abstract][Full Text] [Related]
33. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
34. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination.
Hisahara S; Yuan J; Momoi T; Okano H; Miura M
J Exp Med; 2001 Jan; 193(1):111-22. PubMed ID: 11136825
[TBL] [Abstract][Full Text] [Related]
35. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
36. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F
Adv Exp Med Biol; 2006; 586():139-51. PubMed ID: 16893070
[No Abstract] [Full Text] [Related]
37. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
38. Sildenafil ameliorates EAE by decreasing apoptosis in the spinal cord of C57BL/6 mice.
Duarte-Silva E; Araújo SMDR; Oliveira WH; Lós DB; França MER; Bonfanti AP; Peron G; Thomaz LL; Verinaud L; Nunes AKS; Peixoto CA
J Neuroimmunol; 2018 Aug; 321():125-137. PubMed ID: 29957383
[TBL] [Abstract][Full Text] [Related]
39. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
40. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.
Calida DM; Constantinescu C; Purev E; Zhang GX; Ventura ES; Lavi E; Rostami A
J Immunol; 2001 Jan; 166(2):723-6. PubMed ID: 11145641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]